Sign inJoin waitlistJoin the waitlist

Betul Oran

Professor of Medicine · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Internal Medicine
Boston University
2006–2008
University of Texas M D Anderson Cancer Center
2004–2005
Hematology and Medical Oncology
Boston University
2001–2004
Hacettepe University
1996–2001
Doctor of Medicine
1991–1995

Research

Cord-blood engraftment with ex vivo mesenchymal-cell coculture
New England Journal of Medicine · 2012 · 371 citations
Survival for older patients with acute myeloid leukemia: a population-based study
Haematologica · 2012 · First of 2 authors · Corresponding · 346 citations
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nature Medicine · 2018 · 251 citations

Richard Champlin
134 papers
Uday Popat
129 papers
Elizabeth Shpall
114 papers
Partow Kebriaei
101 papers
Amin Alousi
80 papers
Chitra Hosing
80 papers
Rohtesh Mehta
66 papers · 6 as a fellow
Muzaffar Qazilbash
63 papers
AO
Amanda Olson
62 papers
Stefan Ciurea
62 papers
Qaiser Bashir
59 papers
KR
Katayoun Rezvani
53 papers

Grants

Clonal Evolution and Immune Dysregulation in AML Patients Treated with Venetoclax and Azacitidine After Allogeneic Stem Cell Transplantation
National Cancer Institute · R21
Contact PI · $421.7K · University of Tx Md Anderson Can Ctr
2026–2028

Clinical trials

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
2024
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2020–2026
Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2016–2024
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2015–2019